Showing results (151-160 of 524) with videos related to
Sort By:
Pageof 53
Carcinogenesis|October 1, 1986
Changing responsiveness to all-trans retinoic acid of rat tracheal epithelial cells at different stages of neoplastic transformationD J Fitzgerald, J C Barrett, P NettesheimBiochemical Society Transactions|March 25, 2005
Using proteomics to identify potential therapeutic targets in plateletsP B Maguire, M Foy, D J FitzgeraldProceedings of the National Academy of Sciences of the United States of America|September 1, 1986
Antitumor effects of an immunotoxin made with Pseudomonas exotoxin in a nude mouse model of human ovarian cancerD J FitzGerald, M C Willingham, I PastanCancer Treatment and Research|January 1, 1988
Pseudomonas exotoxin--immunotoxinsD J FitzGerald, M C Willingham, I PastanThe Journal of Pharmacology and Experimental Therapeutics|August 8, 1998
Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivoN P Murphy, D Pratico, D J FitzgeraldNeurology|January 1, 1985
Prostacyclin biosynthesis and platelet function in autonomic dysfunctionM R Goldberg, D Robertson, G A FitzGeraldThe Journal of Biological Chemistry|April 28, 1995
Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alphaD Pratico, J A Lawson, G A FitzGeraldThe Journal of Biological Chemistry|September 25, 1990
Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levelsC B Siegall, D J FitzGerald, I PastanBiochemistry|April 14, 1992
Translocation mediated by domain II of Pseudomonas exotoxin A: transport of barnase into the cytosolT I Prior, D J FitzGerald, I PastanThe Journal of Pharmacology and Experimental Therapeutics|June 1, 1997
Interaction of a thrombin inhibitor and a platelet GP IIb/IIIa antagonist in vivo: evidence that thrombin mediates platelet aggregation and subsequent thromboxane A2 formation during coronary thrombolysisD Pratico, N P Murphy, D J FitzgeraldPageof 53